RxDoctor Payments Data

Clari Salgado Rios, MD

General Practice · Dorado, PRNPI 1801052485

Payments from drug & device makers

$1,124in general payments, 2019–2025

Across 55 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$190
  • AbbVie$152
  • Pfizer$112
  • Novo Nordisk$95
  • AstraZeneca$84
  • Biohaven Pharmaceuticals, Inc.$78
  • plus $413 from 13 others

What the payments were for

  • Food & beverage$1,124100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,124 in reported general payments places this provider in the 85th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$7,472
Medicare patients
53
Services billed
104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$65,193
JardianceEmpagliflozin35$51,847
OzempicSemaglutide37$46,966
TrulicityDulaglutide13$35,433
MyrbetriqMirabegron22$18,595
JanuviaSitagliptin Phosphate18$18,054
XareltoRivaroxaban14$17,976
FarxigaDapagliflozin Propanediol12$14,454
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$13,986
Gabapentin178$3,581
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$3,323
Atorvastatin Calcium455$3,259
Celecoxib25$3,123
Albuterol Sulfate HfaAlbuterol Sulfate117$3,071
Losartan Potassium252$2,299

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$112$65,19356 claims
Boehringer IngelheimJardiance$39$51,84735 claims
Novo NordiskOzempic$95$46,96637 claims
Lilly USA, LLCTrulicity$190$35,43313 claims
Johnson & JohnsonXarelto$39$17,97614 claims
AstraZenecaFarxiga$84$14,45412 claims
GSKTrelegy Ellipta$24$13,98614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in Dorado

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →